Efficacy of Quetiapine Monotherapy and Combination Therapy for Patients with Bipolar Depression with Mixed Features: A Randomized Controlled Pilot Study

Effective pharmacotherapy of bipolar depression with mixed features defined by DSM-5 remains unclear in clinical treatment guidelines. Quetiapine (QTP) and valproate have potential treatment utility but are often inadequate as monotherapy. Meanwhile, the efficacy of combination therapies of QTP plus...

Full description

Bibliographic Details
Main Authors: Zheng Wang, Danhua Zhang, Yanli Du, Yin Wang, Tingting Huang, Chee H. Ng, Huimin Huang, Yanmeng Pan, Jianbo Lai, Shaohua Hu
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/16/2/287
_version_ 1797618817872953344
author Zheng Wang
Danhua Zhang
Yanli Du
Yin Wang
Tingting Huang
Chee H. Ng
Huimin Huang
Yanmeng Pan
Jianbo Lai
Shaohua Hu
author_facet Zheng Wang
Danhua Zhang
Yanli Du
Yin Wang
Tingting Huang
Chee H. Ng
Huimin Huang
Yanmeng Pan
Jianbo Lai
Shaohua Hu
author_sort Zheng Wang
collection DOAJ
description Effective pharmacotherapy of bipolar depression with mixed features defined by DSM-5 remains unclear in clinical treatment guidelines. Quetiapine (QTP) and valproate have potential treatment utility but are often inadequate as monotherapy. Meanwhile, the efficacy of combination therapies of QTP plus valproate or lithium have yet to be verified. Hence, we conducted a randomized controlled pilot study to evaluate the efficacy of QTP monotherapy in patients with bipolar depression with mixed features defined by DSM-5 and compared the combination therapy of QTP plus valproate (QTP + V) versus QTP plus lithium (QTP + L) for those patients who responded insufficiently to QTP monotherapy. Data was analyzed according to the intent-to-treat population. Generalized linear mixed model was performed by using “nlme” package in R software. A total 56 patients were enrolled, among which, 35 patients responded to QTP alone, and 11 and 10 patients were randomly assigned to QTP + V and QTP + L group, respectively. Nearly 60% enrolled patients responded to QTP monotherapy at the first two weeks treatment. No statistically significant difference in efficacy between QTP + V and QTP + L was observed. In conclusion, QTP monotherapy appeared to be efficacious in patients with bipolar depression with mixed features, and for those who responded insufficiently to QTP, combining with either valproate or lithium appeared to have positive effects.
first_indexed 2024-03-11T08:17:55Z
format Article
id doaj.art-6fc480fd03eb42f9a42e3303591e4a96
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-11T08:17:55Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-6fc480fd03eb42f9a42e3303591e4a962023-11-16T22:37:34ZengMDPI AGPharmaceuticals1424-82472023-02-0116228710.3390/ph16020287Efficacy of Quetiapine Monotherapy and Combination Therapy for Patients with Bipolar Depression with Mixed Features: A Randomized Controlled Pilot StudyZheng Wang0Danhua Zhang1Yanli Du2Yin Wang3Tingting Huang4Chee H. Ng5Huimin Huang6Yanmeng Pan7Jianbo Lai8Shaohua Hu9Department of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, ChinaDepartment of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, ChinaDepartment of Psychiatry, Dongyang People’s Hospital, Jinhua 322103, ChinaClinical Trial Unit, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai 310005, ChinaAffiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou 310003, ChinaDepartment of Psychiatry, The Melbourne Clinic and St Vincent’s Hospital, University of Melbourne, Richmond, VIC 3121, AustraliaDepartment of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, ChinaDepartment of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, ChinaDepartment of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, ChinaDepartment of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, ChinaEffective pharmacotherapy of bipolar depression with mixed features defined by DSM-5 remains unclear in clinical treatment guidelines. Quetiapine (QTP) and valproate have potential treatment utility but are often inadequate as monotherapy. Meanwhile, the efficacy of combination therapies of QTP plus valproate or lithium have yet to be verified. Hence, we conducted a randomized controlled pilot study to evaluate the efficacy of QTP monotherapy in patients with bipolar depression with mixed features defined by DSM-5 and compared the combination therapy of QTP plus valproate (QTP + V) versus QTP plus lithium (QTP + L) for those patients who responded insufficiently to QTP monotherapy. Data was analyzed according to the intent-to-treat population. Generalized linear mixed model was performed by using “nlme” package in R software. A total 56 patients were enrolled, among which, 35 patients responded to QTP alone, and 11 and 10 patients were randomly assigned to QTP + V and QTP + L group, respectively. Nearly 60% enrolled patients responded to QTP monotherapy at the first two weeks treatment. No statistically significant difference in efficacy between QTP + V and QTP + L was observed. In conclusion, QTP monotherapy appeared to be efficacious in patients with bipolar depression with mixed features, and for those who responded insufficiently to QTP, combining with either valproate or lithium appeared to have positive effects.https://www.mdpi.com/1424-8247/16/2/287bipolar depression with mixed featuresquetiapinevalproatelithiummonotherapycombination therapy
spellingShingle Zheng Wang
Danhua Zhang
Yanli Du
Yin Wang
Tingting Huang
Chee H. Ng
Huimin Huang
Yanmeng Pan
Jianbo Lai
Shaohua Hu
Efficacy of Quetiapine Monotherapy and Combination Therapy for Patients with Bipolar Depression with Mixed Features: A Randomized Controlled Pilot Study
Pharmaceuticals
bipolar depression with mixed features
quetiapine
valproate
lithium
monotherapy
combination therapy
title Efficacy of Quetiapine Monotherapy and Combination Therapy for Patients with Bipolar Depression with Mixed Features: A Randomized Controlled Pilot Study
title_full Efficacy of Quetiapine Monotherapy and Combination Therapy for Patients with Bipolar Depression with Mixed Features: A Randomized Controlled Pilot Study
title_fullStr Efficacy of Quetiapine Monotherapy and Combination Therapy for Patients with Bipolar Depression with Mixed Features: A Randomized Controlled Pilot Study
title_full_unstemmed Efficacy of Quetiapine Monotherapy and Combination Therapy for Patients with Bipolar Depression with Mixed Features: A Randomized Controlled Pilot Study
title_short Efficacy of Quetiapine Monotherapy and Combination Therapy for Patients with Bipolar Depression with Mixed Features: A Randomized Controlled Pilot Study
title_sort efficacy of quetiapine monotherapy and combination therapy for patients with bipolar depression with mixed features a randomized controlled pilot study
topic bipolar depression with mixed features
quetiapine
valproate
lithium
monotherapy
combination therapy
url https://www.mdpi.com/1424-8247/16/2/287
work_keys_str_mv AT zhengwang efficacyofquetiapinemonotherapyandcombinationtherapyforpatientswithbipolardepressionwithmixedfeaturesarandomizedcontrolledpilotstudy
AT danhuazhang efficacyofquetiapinemonotherapyandcombinationtherapyforpatientswithbipolardepressionwithmixedfeaturesarandomizedcontrolledpilotstudy
AT yanlidu efficacyofquetiapinemonotherapyandcombinationtherapyforpatientswithbipolardepressionwithmixedfeaturesarandomizedcontrolledpilotstudy
AT yinwang efficacyofquetiapinemonotherapyandcombinationtherapyforpatientswithbipolardepressionwithmixedfeaturesarandomizedcontrolledpilotstudy
AT tingtinghuang efficacyofquetiapinemonotherapyandcombinationtherapyforpatientswithbipolardepressionwithmixedfeaturesarandomizedcontrolledpilotstudy
AT cheehng efficacyofquetiapinemonotherapyandcombinationtherapyforpatientswithbipolardepressionwithmixedfeaturesarandomizedcontrolledpilotstudy
AT huiminhuang efficacyofquetiapinemonotherapyandcombinationtherapyforpatientswithbipolardepressionwithmixedfeaturesarandomizedcontrolledpilotstudy
AT yanmengpan efficacyofquetiapinemonotherapyandcombinationtherapyforpatientswithbipolardepressionwithmixedfeaturesarandomizedcontrolledpilotstudy
AT jianbolai efficacyofquetiapinemonotherapyandcombinationtherapyforpatientswithbipolardepressionwithmixedfeaturesarandomizedcontrolledpilotstudy
AT shaohuahu efficacyofquetiapinemonotherapyandcombinationtherapyforpatientswithbipolardepressionwithmixedfeaturesarandomizedcontrolledpilotstudy